Effect Of Ciprofloxacin And Resveratrol Combination On Expression of pelA , pslD, mexA Genes of Pseudomonas aeruginosa isolates from lower respiratory tracts.
DOI:
https://doi.org/10.24237/Keywords:
: P.aeruginosa, pelA, pslD, and mexA genes , Biofilom , Resveratrol , CiprofloxacinAbstract
A total of 200 sputum specimens were collected from the patients infection with Lower Respiratory Tract ( LRT) who attended Baquba Teaching Hospital and Chest Diseases Center Baquab city /Iraq. The study aimed to investigate the effect of resveratrol as efflux pumps inhibitor on ciprofloxacin MIC and compare the effect of two agents on expression of pelA , pslD, mexA genes for P. aeruginosa isolates ,all specimens were inoculated on suitable media for isolation and identification of bacteria by morphological , biochemical tests and molecular diagnosis using the polymerase chain reaction .The results showed that overall prevalence of P. aeruginosa among patients was 24 (12%) isolates were identified .The percentages of the phenotypic detection haemolysin test , pyocinin pigment 100 % and 95.83% respectively. Our study reveal that sub-MIC of Resveratrol cause reduction in MIC of Ciprofloxacin for most isolates, . The combination effect of of resveratrol and Ciprofloxacin on the expression of Biofilms formation genes pelA, psID and efflux pump gene mexA revealed a synergistic impact were cause a reduction in mean of gene expression of this three genes ( 0.45 , 0. 60 . 0.90 ) respectively in three MDR P. aeruginosa isolates.
Downloads
References
[1] R. Farhan, A. Hanora, M. M. Azab, S. Solyman, Detection of resistant and biofilm forming Pseudomonas aeruginosa isolated from burn patients in Ismailia governorate, Records of Pharmaceutical and Biomedical Sciences, 7(2),143-51(2023), DOI(https://doi.org/10.21608/rpbs.2023.210346.1226)
[2] D. Reynolds, M. Kollef, The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update, Drugs, 81(18),2117-31(2021), DOI(https://doi.org/10.1007/s40265-021-01635-6)
[3] D. Bilton, Update on non-cystic fibrosis bronchiectasis, Current opinion in pulmonary Medicine,14(6), 595-9(2008), DOI(https://doi.org/10.1097/mcp.0b013e328312ed8c)
[4] M. Loebinger, A. Wells, D. Hansell, N. Chinyanganya, A. Devaraj, M. Meister, Mortality in bronchiectasis: a long-term study assessing the factors influencing survival, European Respiratory Journal, 34(4), 843-9(2009), DOI(https://doi.org/10.1183/09031936.00003709)
[5] DL. Ferguson, ES. Gloag, MR. Parsek, DJ. Wozniak, Extracellular DNA enhances biofilm integrity and mechanical properties of mucoid Pseudomonas aeruginosa, Journal of Bacteriology, 205(10), e00238-23(2023), DOI(https://doi.org/10.1128/jb.00238-23)
[6] S. Basak, S. Das, Pseudomonas aeruginosa, the Superbug, (Cambridge Scholars Publishing, 2022)
[7] MA. Webber, LJ. Piddock, The importance of efflux pumps in bacterial antibiotic resistance, Journal Of Antimicrobial Chemotherapy, 51(1), 9-11(2003), DOI(https://doi.org/10.1093/jac/dkg050)
[8] AL. Colclough, I. Alav, EE. Whittle, HL. Pugh, EM. Darby, SW. Legood, RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance, Future Microbiology, 15(2),143-57(2020), DOI(https://doi.org/10.2217/fmb-2019-0235)
[9] G. Cabot, AA. Ocampo-Sosa, F. Tubau, MD. Macia, C. Rodríguez, B. Moya, Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study, Antimicrobial Agents and Chemotherapy, 55(5), 1906-11(2011), DOI(https://doi.org/10.1128/aac.01645-10)
[10] FF. Tuon, LR. Dantas, PH. Suss, VS. Tasca Ribeiro, Pathogenesis of the Pseudomonas aeruginosa biofilm: a review, Pathogens, 11(3), 300(2022), DOI(https://doi.org/10.3390/pathogens11030300)
[11] Z. He, Z. Huang, W. Zhou, Z. Tang, R. Ma, J. Liang, Anti-biofilm activities from resveratrol against Fusobacterium nucleatum, Frontiers in Microbiology, 7, 1065(2016), DOI(https://doi.org/10.3389/fmicb.2016.01065)
[12] DA. Rasko, V.Sperandio, Anti-virulence strategies to combat bacteria-mediated disease, Nature Reviews Drug discovery, 9(2),117-28(2010), DOI(https://doi.org/10.1038/nrd3013)
[13] M. Vestergaard, H. Ingmer, Antibacterial and antifungal properties of resveratrol, International Journal of Antimicrobial Agents, 53(6),716-23(2019), DOI(https://doi.org/10.1016/j.ijantimicag.2019.02.015)
[14] J. W. Zhou, T. T. Chen, X. J. Tan, J. Y. Sheng, A. Q. Jia, Can the quorum sensing inhibitor resveratrol function as an aminoglycoside antibiotic accelerant against Pseudomonas aeruginosa, International journal of Antimicrobial Agents, 52(1), 35-41(2018), DOI(https://doi.org/10.1016/j.ijantimicag.2018.03.002)
[15] P. Tille, Bailey & Scott's diagnostic microbiology-E-Book: Elsevier Health Sciences,(2015)
[16] JG. Cappuccino, N. Sherman Microbiology: a laboratory manual: Pearson Higher Ed, (2013).
[17] DI. Andersson, D. Hughes, Microbiological effects of sublethal levels of antibiotics, Nature Reviews Microbiology, 12(7), 465-478(2014), DOI(https://doi.org/10.1038/nrmicro3270)
[18] F. MKK, R. MA, S. Rashid, N. MHM, Detection of virulence factors and beta-lactamase encoding genes among the clinical isolates of Pseudomonas aeruginosa, arXiv preprint arXiv:190202014(2019), DOI(https://doi.org/10.31838/ijpr/2019.11.01.031)
[19] KM. Colvin, VD. Gordon, K. Murakami, BR. Borlee, DJ. Wozniak, G. C.Wong, The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa, PLoS Pathogens, 7(1), e1001264(2011), DOI(https://doi.org/10.1074/jbc.M115.674929)
[20] M. Banar, M. Emaneini, M. Satarzadeh, N. Abdellahi, R. Beigverdi, WB. Leeuwen, Evaluation of mannosidase and trypsin enzymes effects on biofilm production of Pseudomonas aeruginosa isolated from burn wound infections, PloS One, 11(10), e0164622(2016), DOI(https://doi.org/10.1371/journal.pone.0164622)
[21] B. Ozer, N. Duran, Y. Onlen, L. Savas, Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit, The Journal of Antibiotics, 65(1), 9-13(2012), DOI(https://doi.org/10.1038/ja.2011.102)
[22] Q. Chang, T. Amemiya, J. Liu, X. Xu, N. Rajendran, K. Itoh, Identification and validation of suitable reference genes for quantitative expression of xylA and xylE genes in Pseudomonas putida mt-2, Journal of Bioscience And Bioengineering, 107(2), 210-4(2009), DOI(https://doi.org/10.1016/j.jbiosc.2008.09.017)
[23] S. Chakravarty, CN. Melton, A. Bailin, TL. Yahr, GG. Anderson, Pseudomonas aeruginosa magnesium transporter MgtE inhibits type III secretion system gene expression by stimulating rsmYZ transcription, Journal of Bacteriology, 199(23),10.1128/jb. 00268-17(2017), DOI(https://doi.org/10.1128/jb.00268-17)
[24] MR. Green, J. Sambrook, Molecular cloning, A Laboratory Manual, 4th ed., 448(2012)
[25] D. Parai, M. Banerjee, P. Dey, A. Chakraborty, E. Islam, SK. Mukherjee, Effect of reserpine on Pseudomonas aeruginosa quorum sensing mediated virulence factors and biofilm formation, Biofouling, 34(3), 320-34(2018), DOI(https://doi.org/10.1080/08927014.2018.1437910)
[26] K. Carroll, J. Hobden, Pseudomonads and Acinetobacter, Jawetz, Melnick, & Adelberg’s Medical Microbiology, (McGraw-Hill Education, New York Carroll KC JA Hobden, 2016), 245-251
[27] KK. Aryal, S. Mehata, S. Neupane, A. Vaidya, M. Dhimal, P. Dhakal, The burden and determinants of non communicable diseases risk factors in Nepal: findings from a nationwide STEPS survey, PloS one, 10(8), e0134834(2015), DOI(https://doi.org/10.1371/journal.pone.0134834)
[28] M. Zainab, Detection of CTX-M-1 and CTX-M-3 genes in virulent, multidrug resistant Pseudomonas aeruginosa isolates: M. Sc. Thesis, College Of Education For Pure Science/Diyala University,(2017)
[29] K. Todar, Pseudomonas and related bacteria, Todar’s online text book of bacteriology, (2004)
[30] NMH. Al-mamari, Isolation and Identification of Pseudomonas aeruginosa from Some Clinical And Environmental Samples And Study It, s Activity for The Production of Pyocyanin and Protease, Journal of Education and Science, 28(4), 93-107(2019), DOI(https://doi.org/10.33899/edusj.1970.163328)
[31] T. Spilker, T. Coenye, P. Vandamme, JJ. LiPuma, PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients, Journal of Clinical Microbiology, 42(5), 2074-2079(2004), DOI(https://doi.org/10.1128/jcm.42.5.2074-2079.2004)
[32] AJ. Seukep, V. Kuete, L. Nahar, SD. Sarker, M. Guo, Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification, Journal of Pharmaceutical Analysis, 10(4), 277-90(2020), DOI(https://doi.org/10.1016/j.jpha.2019.11.002)
[33] M. Stavri, LJ. Piddock, S. Gibbons, Bacterial efflux pump inhibitors from natural sources, Journal of Antimicrobial Chemotherapy, 59(6), 1247-60(2007), DOI(https://doi.org/10.1093/jac/dkl460)
[34] PD. Gupta, TJ. Birdi, Development of botanicals to combat antibiotic resistance, Journal of Ayurveda and Integrative Medicine, 8(4), 266-75(2017), DOI(https://doi.org/10.1016/j.jaim.2017.05.004)
[35] R. Kumar, S. Pooja Patial, A review on efflux pump inhibitors of gram-positive and gram-negative bacteria from plant sources, Int J Curr Microbiol Appl Sci., 5(6), 834-55(2016), DOI(https://doi.org/10.20546/ijcmas.2016.506.092)
[36] P. Maita, K. Boonbumrung, Association between biofilm formation of Pseudomonas aeruginosa clinical isolates versus antibiotic resistance and genes involved with biofilm, (2014)
[37] I. Sharma, D. Choudhury, Detection of Pel A gene in P. aeruginosa from clinical samples using polymerase chain reaction with reference to biofilm production in NE India. Ind J Res. 4, 119-21(2015)
[38] D. Badal, AV. Jayarani, MA. Kollaran, A. Kumar, V. Singh, Pseudomonas aeruginosa biofilm formation on endotracheal tubes requires multiple two-component systems, Journal of Medical Microbiology, 69(6), 906-19(2020), DOI(https://doi.org/10.1099/jmm.0.001199)
[39] G. Wareth, C. Brandt, LD. Sprague, H. Neubauer, MW. Pletz, WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective, BMC Microbiology, 21, 1-13(2021), DOI(https://doi.org/10.1186/s12866-021-02270-7)
[40] M. Ali, S. Suhad, Molecular detection for efflux pump adeIJK genes of multi-drug resistance Acinetobacter baumannii isolated from different clinical sources, Mcs thesis, (2021)
[41] C. Xu, S. Bilya, W. Xu, adeABC efflux gene in Acinetobacter baumannii, New microbes and new infections, 30, 100549(2019), DOI(https://doi.org/10.1016/j.nmni.2019.100549)
[42] R. Kaviani, I. Pouladi, M. Niakan, R. Mirnejad, Molecular detection of adefg efflux pump genes and their contribution to antibiotic resistance in Acinetobacter baumannii clinical isolates, Reports of Biochemistry & Molecular Biology, 8(4), 413(2020)
[43] T. Al Jumaily, RB. Rose'Meyer, A. Sweeny, R. Jayasinghe, Cardiac damage associated with stress hyperglycaemia and acute coronary syndrome changes according to level of presenting blood glucose, International Journal of Cardiology, 196, 16-21(2015), DOI(https://doi.org/10.1016/j.ijcard.2015.05.143)
[44] MH. Zaki, T. Sayed, Automated analysis of pedestrian group behavior in urban settings, IEEE Transactions on Intelligent Transportation Systems, 19(6), 1880-9(2017), DOI(https://doi.org/10.1109/TITS.2017.2747516)
[45] L. Liu, C. Beck, K. Nøhr-Meldgaard, A. Peschel, D. Kretschmer, H. Ingmer, Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides, Scientific Reports, 10(1), 11391(2020), DOI(https://doi.org/10.1038/s41598-020-68146-4)
[46] CB. Landersdorfer, NS. Ly, H. Xu, BT. Tsuji, JB. Bulitta, Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design, Antimicrobial Agents and Chemotherapy, 57(5), 2343-51(2013), DOI(https://doi.org/10.1128/AAC.00092-13)
[47] Z. Lou, KS. Letsididi, F. Yu, Z. Pei, H. Wang, R. Letsididi, Inhibitive effect of eugenol and its nanoemulsion on quorum sensing–mediated virulence factors and biofilm formation by Pseudomonas aeruginosa, Journal of Food Protection, 82(3), 379-89(2019), DOI(https://doi.org/10.4315/0362-028x.jfp-18-196)
[48] S. Gutierrez, A. Morán, H. Martínez-Blanco, MA. Ferrero, LB. Rodríguez-Aparicio, The usefulness of non-toxic plant metabolites in the control of bacterial proliferation, Probiotics and Antimicrobial Proteins, 9, 323-33(2017), DOI(https://doi.org/10.1007/s12602-017-9259-9)
[49] J. Rajkumari, S. Borkotoky, A. Murali, K. Suchiang, SK. Mohanty, S. Busi, Attenuation of quorum sensing controlled virulence factors and biofilm formation in Pseudomonas aeruginosa by pentacyclic triterpenes, betulin and betulinic acid, Microbial Pathogenesis, 118, 48-60(2018), DOI(https://doi.org/10.1016/j.micpath.2018.03.012)
[50] Y. Shuster, S. Steiner-Mordoch, N. Alon Cudkowicz, S. Schuldiner, A transporter interactome is essential for the acquisition of antimicrobial resistance to antibiotics, PLoS One, 11(4), e0152917(2016), DOI(https://doi.org/10.1371/journal.pone.0152917)
[51] LJ. Piddock, MI. Garvey, MM. Rahman, S. Gibbons, Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria, Journal of Antimicrobial Chemotherapy, 65(6), 1215-23(2010), DOI(https://doi.org/10.1093/jac/dkq079)
[52] G. Spengler, A. Kincses, M. Gajdács, L. Amaral, New roads leading to old destinations: efflux pumps as targets to reverse multidrug resistance in bacteria, Molecules, 22(3), 468(2017), DOI(https://doi.org/10.3390/molecules22030468)
Downloads
Published
Issue
Section
License
Copyright (c) 2025 CC BY 4.0
This work is licensed under a Creative Commons Attribution 4.0 International License.
